Total population | Propensity-matched population | |||||
Low HDL-C (n=1585) | High HDL-C (n=1108) | p Value | Low HDL-C (n=990) | High HDL-C (n=990) | p Value | |
At index PCI | ||||||
Glucose, mg/dl | 137.2±65.3 | 126.9±51.1 | <0.001 | 132.7±61.1 | 128.7±53.1 | 0.133 |
HbA1C (%) | 6.7±1.5 | 6.4±1.4 | 0.001 | 6.6±1.5 | 6.5±1.4 | 0.290 |
Creatinine, mg/dl | 1.13±0.96 | 1.09±0.90 | 0.325 | 1.11±0.86 | 1.09±0.84 | 0.595 |
Total cholesterol, mg/dl | 173.5±40.6 | 176.6±39.4 | 0.049 | 173.0±40.2 | 177.6±39.8 | 0.012 |
Triglyceride, mg/dl | 154.9±138.8 | 138.8±120.1 | <0.001 | 159.0±122.0 | 137.4±104.6 | <0.001 |
LDL-C, mg/dl | 107.0±33.4 | 105.9±36.5 | 0.432 | 107.0±30.3 | 106.9±34.7 | 0.962 |
HDL-C, mg/dl | 38.9±9.5 | 48.3±11.4 | <0.001 | 38.5±8.7 | 48.2±11.2 | <0.001 |
hs-CRP, mg/l | 1.68±6.55 | 1.09±5.93 | 0.025 | 1.51±7.18 | 1.15±6.224 | 0.261 |
Follow-up lab after PCI | ||||||
Glucose, mg/dl | 123.8±52.3 | 118.3±42.3 | 0.004 | 120.3±45.1 | 119.6±43.7 | 0.758 |
HbA1C (%) | 6.8±1.5 | 0.001 | 6.7±1.4 | 6.6±1.3 | 0.483 | |
Creatinine, mg/dl | 1.18±1.13 | 1.11±0.91 | 0.061 | 1.14±1.0 | 1.10±0.87 | 0.428 |
Total cholesterol, mg/dl | 129.0±28.0 | 140.1±23.2 | <0.001 | 129.6±28.6 | 140.0±23.2 | <0.001 |
Triglyceride, mg/dl | 151.0±114.0 | 114.1±77.9 | <0.001 | 152.4±117.0 | 113.0±74.6 | <0.001 |
LDL-C, mg/dl | 70.8±27.5 | 69.3±16.7 | 0.005 | 68.8±16.7 | 68.9±16.8 | 0.924 |
HDL-C, mg/dl | 37.5±6.04 | 52.3±9.7 | <0.001 | 35.3±6.0 | 52.4±9.6 | <0.001 |
hs-CRP, mg/l | 1.10±9.46 | 0.59±2.07 | 0.072 | 1.31±11.8 | 0.59±2.03 | 0.086 |
Data are presented as mean±SD.
HDL-C, high-density lipoprotein cholesterol; hs-CRP, high sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; PCI, percutaneous coronary intervention.